ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.

85,013 comparisons

Most participants first33,758 with no events in either group come last61 to 80 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
Polypharmacy vs No Polypharmacy: Complications31,570 of 146,029

19,815 of 120,470

5.2 points

4.9 to 5.5

266,499NCT03133182

Polypharmacy and Outcomes After Elective Noncardiac Surgery

Polypharmacy vs No Polypharmacy: deaths from any cause4,356 of 146,029

1,919 of 120,470

1.4 points

1.3 to 1.5

266,499NCT03133182

Polypharmacy and Outcomes After Elective Noncardiac Surgery

Polypharmacy vs No Polypharmacy: Mortality4,356 of 146,029

1,919 of 120,470

1.4 points

1.3 to 1.5

266,499NCT03133182

Polypharmacy and Outcomes After Elective Noncardiac Surgery

Intervention Arm vs Usual Care Arm: COVID-19 Booster Vaccination56,408 of 116,319

63,909 of 143,669

4.0 points

3.6 to 4.4

259,988NCT05027464

Developing and Testing a COVID-19 Vaccination Acceptance Intervention

Intervention vs Control: Number of Participants With Opioid Prescription Within 90 Days of Index Imaging32,873 of 121,431

37,322 of 117,455

-4.7 points

-5.1 to -4.3

238,886NCT02015455

Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports

Intervention vs Control: Number of Participants With an Opioid Prescription Within 30 Days of Index Imaging27,165 of 121,431

31,035 of 117,455

-4.1 points

-4.4 to -3.7

238,886NCT02015455

Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports

Intervention vs Control: deaths from any cause953 of 121,431

958 of 117,455

-0.0 points

-0.1 to 0.0

238,886NCT02015455

Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports

Intervention vs Control: Number of Participants With Opioid Prescription Within 12 Months of Index Imaging41,205 of 121,431

46,220 of 117,455

-5.4 points

-5.8 to -5.0

238,886NCT02015455

Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports

Intervention vs Control: Number of Participants With Spine Surgery Within 18 Month of Index Imaging3,785 of 121,431

3,753 of 117,455

-0.1 points

-0.2 to 0.1

238,886NCT02015455

Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports

Intervention vs Control: serious adverse events13,289 of 121,431

12,885 of 117,455

-0.0 points

-0.3 to 0.2

238,886NCT02015455

Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports

Storage Container vs Control: Incidence of All Self-harm1,217 of 114,168

1,220 of 109,693

-0.0 points

-0.1 to 0.0

223,861NCT01146496

A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia

Storage Container vs Control: Incidence of All Self-poisoning1,155 of 114,168

1,173 of 109,693

-0.1 points

-0.1 to 0.0

223,861NCT01146496

A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia

Storage Container vs Control: Incidence of Unintentional Paediatric Pesticide Poisoning18 of 114,168

15 of 109,693

0.0 points

-0.0 to 0.0

223,861NCT01146496

A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia

Storage Container vs Control: Incidence of Fatal Self-harm82 of 114,168

67 of 109,693

0.0 points

-0.0 to 0.0

223,861NCT01146496

A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia

Storage Container vs Control: Incidence of Pesticide Poisoning633 of 114,168

662 of 109,693

-0.0 points

-0.1 to 0.0

223,861NCT01146496

A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia

Storage Container vs Control: Incidence of Pesticide Self-poisoning611 of 114,168

641 of 109,693

-0.0 points

-0.1 to 0.0

223,861NCT01146496

A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia

Intervention vs Control: Number of Participants With Cross-sectional Imaging Within 90 Days of Plain Film Index Imaging13,099 of 98,970

12,228 of 93,465

0.2 points

-0.1 to 0.5

192,435NCT02015455

Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports

Intervention vs Control: Number of Participants With Cross-sectional Imaging Within 12 Months of Plain Film Index Imaging19,069 of 98,970

18,179 of 93,465

-0.2 points

-0.5 to 0.2

192,435NCT02015455

Trial of Inserting Prevalence Information Into Lumbar Spine Imaging Reports

Biannual Mass Oral Azithromycin vs Biannual Mass Oral Placebo: deaths from any cause3,262 of 97,047

3,392 of 93,191

-0.3 points

-0.4 to -0.1

190,238NCT02047981

Mortality Reduction After Oral Azithromycin: Mortality Study

Biannual Mass Oral Azithromycin vs Biannual Mass Oral Placebo: serious adverse events3,273 of 97,047

3,400 of 93,191

-0.3 points

-0.4 to -0.1

190,238NCT02047981

Mortality Reduction After Oral Azithromycin: Mortality Study

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=4

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03133182-d04a40e3",
        "title": "Polypharmacy vs No Polypharmacy: Complications",
        "summary": "31570 of 146029 against 19815 of 120470; risk difference 5.2 points, 95% interval 4.9 to 5.5; NCT03133182, Polypharmacy and Outcomes After Elective Noncardiac Surgery",
        "record": "/library/comparisons/NCT03133182-d04a40e3",
        "nct_id": "NCT03133182",
        "kind": "outcome",
        "participants": 266499,
        "risk_difference": {
          "value": 0.05170915127837314,
          "lower": 0.04873372862875789,
          "upper": 0.05468011187102711
        },
        "group_1": "31,570 of 146,029",
        "group_2": "19,815 of 120,470",
        "difference": "5.2 points",
        "interval": "4.9 to 5.5",
        "trial_title": "Polypharmacy and Outcomes After Elective Noncardiac Surgery"
      },
      {
        "id": "NCT03133182-deaths",
        "title": "Polypharmacy vs No Polypharmacy: deaths from any cause",
        "summary": "4356 of 146029 against 1919 of 120470; risk difference 1.4 points, 95% interval 1.3 to 1.5; NCT03133182, Polypharmacy and Outcomes After Elective Noncardiac Surgery",
        "record": "/library/comparisons/NCT03133182-deaths",
        "nct_id": "NCT03133182",
        "kind": "deaths",
        "participants": 266499,
        "risk_difference": {
          "value": 0.013900414364251695,
          "lower": 0.012776965020189941,
          "upper": 0.015023645107726096
        },
        "group_1": "4,356 of 146,029",
        "group_2": "1,919 of 120,470",
        "difference": "1.4 points",
        "interval": "1.3 to 1.5",
        "trial_title": "Polypharmacy and Outcomes After Elective Noncardiac Surgery"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=5",
  "request_id": "g9acM9UMAPK_LiJ5"
}
trial-comparisons-2026-03-23-0.1.0Next page

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Open193,990 genes2026-11-11

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?